Optum guides members and providers through important upcoming formulary updates. See multiple tabs of linked spreadsheet for Select, Premium & UM Changes.
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Pyrukynd™(mitapivat) – New orphan drug approval
February 17, 2022 - Agios Pharmaceuticals announced the FDA approval of Pyrukynd (mitapivat), for the treatment of hemolytic anemia in adults with pyruvate kinase (PK) deficiency.
